US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and morenews2026-01-10T11:00:00+00:00January 10th, 2026|Endpoints News|
Eikon Therapeutics files for IPO, testing biotech rallynews2026-01-09T22:14:35+00:00January 9th, 2026|Endpoints News|
How Merck plans to set a buffer for Keytruda’s patent cliffnews2026-01-09T20:03:19+00:00January 9th, 2026|Endpoints News|
Aktis’ 25% IPO bounce builds hope for 2026’s public offeringsnews2026-01-09T18:44:41+00:00January 9th, 2026|Endpoints News|
Orca adds $250M in financing to back launch of T cell therapynews2026-01-09T17:08:30+00:00January 9th, 2026|Endpoints News|
Novartis to build fourth US radiotherapy factory in Florida news2026-01-09T16:36:40+00:00January 9th, 2026|Endpoints News|
Venture firm a16z raises $700M; Ribo Life’s $230M Hong Kong IPOnews2026-01-09T16:26:48+00:00January 9th, 2026|Endpoints News|
BioNTech, UPenn team up for $50M seed fundnews2026-01-09T16:25:30+00:00January 9th, 2026|Endpoints News|
Krystal Biotech says it can deliver native protein to cystic fibrosis patientsnews2026-01-09T15:26:44+00:00January 9th, 2026|Endpoints News|
J&J strikes drug pricing, tariff deal with the White Housenews2026-01-09T14:17:44+00:00January 9th, 2026|Endpoints News|
